LXP-1788

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLXP-1788
Drug Alias NameLXP1788LXP-1788
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsCarcinoma, Renal Cell +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLAUNXP Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLAUNXP Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsCarcinoma, Renal Cell +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A